DeepScribe vs Microsoft Dragon Copilot
A specialist against a platform, and for once the specialisation is specific enough to argue with. DeepScribe reports capturing roughly 40 percent of United States cancer care visits and around 5 million oncology encounters a year, with tuned models across cardiology, urology, gastroenterology, orthopaedics, neurology and nephrology, and it holds the strongest buyer survey rating in the category at 98.8 in the KLAS Emerging Company Spotlight with A plus marks across all six measured categories. Dragon Copilot is broader, better documented and available in more roles and countries. The decisive difference is not capability but retention: DeepScribe's published privacy policy permits keeping personal data beyond the term where it remains necessary, which is the weakest retention position recorded in this index for a product that records patient encounters. For an oncology service line that is a question to close in contract, not a reason to stop.
- Specialty depth stated as a deliberate focus rather than a breadth claim. Roughly 5 million oncology visits a year and about 40 percent of United States cancer care visits documented on the platform, plus tuned models across six further specialties and more than 110 languages.
- The integration is genuinely bidirectional. It reads problems, medications, labs and prior notes before the encounter and writes structured data back into discrete fields after, syncing against the schedule, across Epic, athenahealth, NextGen and eClinicalWorks.
- The strongest independent buyer rating in this category, a 98.8 KLAS Emerging Company Spotlight score with A plus across all six categories and 2025 KLAS top five placements on outcomes, patient experience and clinician experience. KLAS is survey based rather than vendor asserted.
- Data retention is the reason to look hard here. DeepScribe's policy permits retaining personal data as long as it remains necessary, potentially beyond the term of the relationship. Microsoft publishes privacy and data collection white papers and a sub processor list scoped to this product.
- Named certifications rather than a claim of holding relevant ones. DeepScribe's security page states that it holds relevant certifications without naming a single one; Microsoft publishes product level security documentation and platform attestations through a central trust portal.
- Role and geography spread. Physicians, nurses and radiologists as distinct editions across ten countries, against a product concentrated in United States specialty ambulatory care.
Side by Side
| Axis | D DeepScribe |
M Microsoft Dragon Copilot |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
Neither vendor publishes a rate card. Third party estimates for DeepScribe disagree widely, ranging from roughly 350 to 500 US dollars per provider per month, and that spread is itself evidence of a fully gated commercial model rather than a usable benchmark. DeepScribe's SOC 2 reference appears in a 2024 company announcement rather than on a maintained trust centre, so ask for the current report and its type. The KLAS scores cited measure customer satisfaction, not documentation accuracy, and neither vendor publishes an error rate.